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IMPORTANCE Older men are at risk of dying of melanoma.
OBJECTIVE To assess attendance at and clinical outcomes of clinical skin examinations (CSEs)
in older men exposed to a video-based behavioral intervention.
DESIGN, SETTING, AND PARTICIPANTS This was a behavioral randomized clinical trial of a
video-based intervention in men aged at least 50 years. Between June 1 and August 31, 2008,
men were recruited, completed baseline telephone interviews, and were than randomized to
receive either a video-based intervention (n = 469) or brochures only (n = 461; overall
response rate, 37.1%) and were again interviewed 7months later (n = 870; 93.5% retention).
INTERVENTIONS Video on skin self-examination and skin awareness and written
informational materials. The control group received writtenmaterials only.
MAIN OUTCOMES ANDMEASURES Participants who reported a CSEwere asked for the type of
CSE (skin spot, partial body, or whole body), who initiated it, whether the physician noted any
suspicious lesions, and, if so, how lesions were managed. Physicians completed a case report
form that included the type of CSE, who initiated it, the number of suspicious lesions
detected, how lesions were managed (excision, nonsurgical treatment, monitoring, or
referral), and pathology reports after lesion excision or biopsy.
RESULTS Overall, 540 of 870men (62.1%) self-reported a CSE since receiving intervention
materials, and 321 of 540 (59.4%) consented for their physician to providemedical
information (received for 266 of 321 [82.9%]). Attendance of any CSE was similar between
groups (intervention group, 246 of 436 [56.4%]; control group, 229 of 434 [52.8%]), but
men in the intervention group weremore likely to self-report a whole-body CSE (154 of 436
[35.3%] vs 118 of 434 [27.2%] for control group; P = .01). Twomelanomas, 29 squamous cell
carcinomas, and 38 basal cell carcinomas were diagnosed, with a higher proportion of
malignant lesions in the intervention group (60.0% vs 40.0% for controls; P = .03). Baseline
attitudes, behaviors, and skin cancer history were associated with higher odds of CSE and
skin cancer diagnosis.
CONCLUSIONS AND RELEVANCE A video-based interventionmay increase whole-body CSE
and skin cancer diagnosis in older men.
TRIAL REGISTRATION anzctr.org.au Identifier: ACTRN12608000384358
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M elanoma isacommonmalignancyof theskin. InAus-tralia in2008, theage-standardizedratewas65mela-nomas per 100000population,1,2 comparedwith 21
per 100 0003,4 in the United States. Although a stabilization
of incidence rates in younger birth cohorts has been
observed,5,6 the incidence inolder age groups continues to in-
crease in the United States, Australia, and Europe.7,8 In the
United States, death rates frommelanoma have decreased in
women but have increased in men.9
Removing melanomas when they are thin (<1 mm) is as-
sociated with lower morbidity and mortality rates.10-12 Early
detection is an important strategy to reduce the burden of
melanoma13 andcanbeachieved throughvisual inspectionby
a layperson (skin self-examination [SSE]) or a clinician (clini-
cal skin examination [CSE]). In 1996, apopulation-based case-
control study suggested that SSE was associated with a sur-
vivalbenefit.14Acase-control study inQueenslandshowedthat
melanomasdetectedduringdeliberate examinations (bya lay-
person or a physician) were thinner than those detected
otherwise.15 Having 1whole-bodyCSEwithin the past 3 years
can reduceby 14% the risk of diagnosis of a thickmelanoma.16
This may improve 10-year survival rates among screened
(92.6%) vs unscreened (90.4%) melanoma survivors,16 al-
though lead timebiasneeds tobe considered. Clinical skin ex-
aminations have also been shown in other studies to demon-
strate thin melanomas and reduce the incidence of thick
melanomas.15,17-20 A skin cancer screening project in Ger-
many reported a reduction inmortality rates frommelanoma
in a state offering screening byCSE, comparedwith states not
offering CSE screening.21
Approximately30%ofpersonsattendaphysician foraCSE
at least every 3 years,22 but oldermenare less likely thanother
populations to do so.16,21 In addition, other investigators have
found that men have worse survival rates than women even
after controlling for tumor thickness, suggesting that sex-
specific biological factors may play a role in survival. Older
men are also more likely to have diagnoses of thick melano-
mas, and their melanomas are more likely to be fatal.23 A
cost analysis estimated that providing CSEs to men aged at
least 50 years would incur health care costs similar to those
of other early detection programs, such as mammography
for breast cancer or fecal occult blood testing for colorectal
cancer.24 Even so, melanoma screening is currently not rec-
ommended in most countries25 owing to lack of evidence of
a mortality benefit in randomized trials (although 1 trial is
currently ongoing).21,22
The present study forms part of a randomized behavioral
trial of a video-based intervention designed to improve SSE,
skin awareness, and CSE behaviors in men aged at least 50
years. Previous reports from this trial have focused onmeth-
ods and SSE outcomes.26,27 This analysis focused on the pre-
specified secondary aim of the trial to assess CSE attendance
and outcomes. We aimed to assess whether the intervention
increased the proportion of men who presented to a physi-
cian for a CSE, received a whole-body CSE, and received a di-
agnosis of skin cancer. Another aimwas to determine factors
other thanthe interventionorcontrolconditionassociatedwith
having a CSE or skin cancer diagnosis during the trial.
Methods
Ethical approval was received from the Queensland Univer-
sity of Technology’s ethics committee (approval QUT
0600000645). Between June 1 and August 31, 2008, a total of
930 men aged at least 50 years were recruited through ran-
dom selection from the Queensland electoral roll (response
rate, 37.1%) (Figure). Eligibility criteria includedproficiency in
English, access to adigital videodisc (DVD)player, andnopre-
vious history of melanoma. Participants were enrolled into a
randomized clinical trial, the Skin Awareness Study (anzctr
.org.au Identifier: ACTRN12608000384358). All participants
provided written informed consent.
Intervention and Control Conditions
Interventionparticipants receivedbothvideo-basedandwrit-
ten skin awareness educational materials, and control group
participants receivedonly thewritteneducationalmaterials.27
The intervention was underpinned by the Health Belief
Model.28 The video highlighted the seriousness of a mela-
nomadiagnosis (perceivedseriousness according to thehealth
beliefmodel), risk factors formelanoma,and the increased risk
inmen aged at least 50 years (perceived susceptibility); mod-
eled awhole-body SSE (self-efficacy); presented amelanoma
surgeon who encouraged SSE (cues to action) and presenta-
tion to a physician for a whole-body CSE; and showed a CSE
beingperformed (overcomingbarriers). Anational sports per-
sonality along with melanoma survivors encouraged men to
become skin aware (benefit).
Figure. Flow of Participants Through Study and Clinical Skin Examination
(CSE) Outcomes
2899 Assessed for eligibility
624
289
1019
No response
Excluded
Refused participation
968 Consented
38 Withdrew after consent
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469
276
Intervention
Self-reported CSE in 
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follow-up
159 Consented to physician 
being contacted
104 Medical reports obtained 
from physician after 
October 2008
461
264
Control
Self-reported CSE in 
previous 6 mo at 7-mo 
follow-up
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being contacted
107 Medical reports obtained 
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October 2008
Participants were randomized into intervention and control groups.
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Main OutcomeMeasures
Outcomes were the prevalence and frequency of having un-
dergone any type or whole-body CSEs since baseline, as well
as clinical and histopathological outcomes of skin lesions
treated during the past 6months. Overall, 469menwere ran-
domizedto the interventiongroupand461 to thecontrolgroup.
Baseline telephone survey results were available for 929
participants.26,27Atbaseline,80.8%ofmenreported thataphy-
sician had ever checked any part of their skin for early signs
of skin cancer, and 38.8% had undergone a whole-body CSE
within the past 12 months.26
For the present analysis, we used data from a telephone
interviewadministered7months after baseline, alongwith in-
formation from participants’ physicians. Participants were
asked whether they had undergone CSE within the past 6
months. The validity of CSE self-report had been previously
established (93.7%concordancebetween self-report andphy-
sician report for CSE within the past 3 years), with some evi-
dence for telescoping when a shorter interval was assessed
(74.3% concordance for CSE within the past 12 months).29 If
participants reportedhavingundergoneaCSE,weaskedabout
the type of CSE (skin spot, partial body, or whole body), who
initiated it (the participant himself or his physician during a
consultation for another reason),whether thephysiciannoted
anysuspicious lesions,and, if so,howtheyweremanaged.With
participant consent,weasked thephysician to complete a case
report form (eFigure in the Supplement) that included typeof
CSE, who initiated it, number of suspicious lesions detected,
and how lesions were managed (nonsurgical treatment, sur-
gical treatment [excision or biopsy], monitoring, or referral),
and we obtained pathology reports for excisions or biopsies.
Analysiswas restricted toCSEscompletedafter thestudystart-
ing date, October 1, 2008, and before the 7-month interview.
Statistical Analysis
AnalyseswereperformedusingSASsoftware (versions9.2 and
9.3; SAS Institute). Descriptive analyseswere conducted, and
χ2 tests andWilcoxon rank sum tests were used to assess dif-
ferences in self-reportedoutcomesbetween intervention and
control groups; χ2 tests were also used to compare the distri-
bution of physicians’ responses to each question in the case-
report formsanddiagnosticoutcomesbetweentreatmentarms.
Agreement between participant-reported and physician re-
ported data was assessed using the Cohen κ statistic.
Bivariate logistic regression analyses were initially con-
ducted, including demographic and clinical factors, pheno-
typic characteristics, SSE behaviors, and attitudes and social
supportsassociatedwithundergoingat least 1partial-orwhole-
body self-reported CSE during the study period. Multivari-
able logistic regressionwas thenused to assesswhich charac-
teristicswere independentlyassociatedwithself-reportedCSE
after adjustment forothervariables (keydemographicandskin
cancer risk factors, sunprotectionbehaviors, attitudes, andbe-
liefs, asdescribedelsewhere26), including randomization to in-
tervention or control groups. Factorswith aPvalue <.20were
initially included in the multivariable logistic regression, re-
moved individually, and then reentered while we observed
changes in the likelihood ratio to derive the most parsimoni-
ous model. Terms were retained if the P value was less than
.05within themultivariablemodel. Similarly, we established
baseline factors independently associatedwith the diagnosis
of skin cancer (melanoma, squamous cell carcinoma [SCC], or
basal cell carcinoma [BCC]).
Results
Oncebaseline interviewswerecomplete (Table 1presentsbase-
line characteristics), participantswere randomized into inter-
vention and control groups stratified by area of residence
(southeast cornerofvs restofQueensland); randomizationwas
based on a computer-generated random number list gener-
ated separately fromother studyproceduresby the study stat-
istician (P. B.). Given thenature of the intervention, itwasnot
possible tomaskparticipants for their groupassignment;how-
ever, telephone interviewers were working for a professional
telephone survey company independent from the research
teamandmasked toparticipants’ allocations.The7-month fol-
low-up telephone interviews were completed by 870 of 930
men (93.5%of those enrolled); theFigure summarizes partici-
pant flow. Demographic characteristics at baseline have been
described elsewhere.26
Self-reported Outcomes
Overall, at the 7-month interview,475of870men (54.6%) self-
reported that a physicianhaddeliberately checked anypart of
their skin during the past 6months, and these results did not
differ between intervention (246 of 436 [56.4%]) and control
(229 of 434 [52.8%]) groups (P = .28). There was also no dif-
ference in the number of participants who reported that the
physician looked at a skin spot during a consultation for
another reason (intervention, 114 of 436 [26.1%]; control, 112
of 434 [25.8%]). However, participants in the intervention
group (154 of 436 [35.3%]) were significantly more likely
than controls (118 of 434 [27.2%]; P = .01) to report a whole-
body CSE during the past 6 months. Among participants
who reported either a dedicated CSE or skin spot check dur-
ing another consultation, Table 2 compares the distribution
of participants’ self-reported outcomes for these consulta-
tions. Men in the intervention group were more likely to
have been asked by their physician to return for a follow-up
examination (P = .001), but there was no difference between
intervention or control groups in relation to self-reported
skin lesion treatment (Table 2).
In themultivariablemodel, baseline factors positively as-
sociatedwith a self-reported CSEwithin the first 6months of
the trial included having a regular general practitioner (odds
ratio, 1.49; 95% CI, 1.15-1.92), having had a spot or mole re-
moved in thepast (1.45; 1.24-1.71), current concernabouta spot
ormole (1.31; 1.10-1.56), having checked one’s own skin in the
past 6 months (1.15; 1.00-1.33), having undergone CSE in the
previous 12 months (1.47; 1.26-1.70), and sometimes or usu-
allywearing ahat (1.34; 1.01-1.78).Withinmen in the interven-
tiongroupwho reportedat least 1CSE, thosewhowatched the
DVDmore than onceweremore likely to report awhole-body
CSE (62.2%) than thosewhowatched theDVDonce (55.2%) or
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didnotwatch it (50.0%); however, this differencewasnot sta-
tistically significant (P = .34).
Of men who reported undergoing CSE in the previous 6
months, 321 of 540 (59.4%; 159 in the intervention and 162 in
the control group) gave consent for their physician to be con-
tactedby the study teamfor furtherdetails about theCSE.Men
whohadblackhair,noprevioushistoryofskinexcisionor treat-
ment, and no CSE within the 12 months before baseline
were less likely to consent for their physician to be con-
tacted (all P < .05). Men who did not provide consent to con-
tact their physician were less likely to self-report that at
least 1 skin lesion was found during the CSE (84 of 216
[38.9%]) than those who gave permission (165 of 321
[51.4%]; P = .004), and they self-reported a lower distribu-
tion of lesions requiring treatment (median, 2 lesions;
range, 1-15) than men who consented to physician contact
(median, 2 lesions; range, 1-28; P < .001).
In total, medical case report forms and pathology reports
(where applicable) were obtained from the physician for 266
of the 321 men (82.8%) who consented. Of these case report
forms, 211 of 266 (79.3%) were for CSEs conductedwithin the
study period and were used in this analysis (104 in the inter-
vention and 107 in the control group).
Physician-Reported Outcomes
Basedon thecase reports received fromphysicians,men in the
intervention group were more likely to have undergone a
whole-body CSE than those in the control group (74.5% vs
61.4%; P = .046); however, men in both groups were equally
likely to be perceived by the physician as having initiated the
CSE (64.7%vs57.9%;P = .31).After theCSE,physicians treated,
monitored, or referred at least 1 lesion in 76% of participants
(76.0% in the intervention and 76.6% in the control group). Of
those, 49.3%ofparticipants (104of 211) hadnonsurgicalman-
agement of at least 1 lesion (50 of 104 [48.1%] in the interven-
tion and54of 107 [50.5%] in the control group).Manyof them
(86 of 211 [40.8%]) were treated with cryotherapy. Overall,
34.1% (72 of 211) underwent surgical excision or biopsy of at
least 1 lesion (41.3% in the intervention and 27.1% in the con-
trol group;P = .03),with amedianof 2 lesions found (Table 3).
The concordance between self-reported and physician-
reported CSE was moderate for whole-body CSE (Cohen κ
= 0.53) and for management of any lesions (Cohen κ = 0.43).
Pathology reportswere obtained for 130 lesions thatwere
excised or sampled for biopsy (85 in the intervention and 45
in the control group).Overall, 2melanomas, 29 SCCs, 38BCCs,
17 solarkeratoses, 3dysplasticnevi, 9benignnevi, and32other
pigmented or nonpigmented lesions were diagnosed. The 2
melanomaswerediagnosed in interventionparticipants.Thus,
the studyobtained amelanomadetection rate of 2 of 469 (426
per 100 000). In addition, 21 SCCs and 28 BCCswere detected
in 104 interventionparticipants, and8SCCsand 10BCCs in 107
control participants. Significantlymore skin cancerswere de-
tected in the interventiongroup than thecontrol group (60.0%
vs 40.0%, respectively; P = .03) (Table 4).
Factors positively associatedwith a skin cancer diagnosis
duringthetrial includedbeingan interventionparticipant (odds
ratio, 1.45; 95%CI, 1.20-2.08), conducting SSEwithin the past
6 months (1.60; 1.04-2.48), history of treatment for a spot or
mole (1.78; 1.19-2.67), and self-reportedCSEwithin thepast 12
months (2.52; 1.21-5.23).Menwho rarely ornever stayed in the
shade andmenwho tannedwithout burningweremore likely
tohave a skin cancer diagnosed (odds ratio, 1.63 [95%CI, 1.10-
2.43] and 3.24 [1.42-7.38], respectively) (Table 5).
Table 1. Participants’ Baseline Demographic and Health Characteristics
Characteristic
Participants, No. (%)
Intervention
Group
(n = 469)
Control
Group
(n = 460)
Area of Queensland
Urban 234 (49.9) 221 (48.0)
Rural 235 (50.1) 239 (52.0)
Age group, y
50-60 186 (39.7) 206 (44.8)
61-70 170 (36.2) 161 (35.0)
71-90 113 (24.1) 93 (20.2)
Highest level of education
completeda
Less than junior high school 45 (9.6) 39 (8.5)
Completed junior high school 109 (23.3) 131 (28.5)
Completed senior high school 91 (19.4) 76 (16.6)
Trade or technical certificate
or diploma
107 (22.8) 120 (26.1)
University or college degree 117 (24.9) 93 (20.2)
Employment status
Employed full time 189 (40.3) 199 (43.3)
Employed part time or casual 48 (10.2) 58 (12.6)
Permanently ill/unable to work/
looking for work
19 (4.0) 21 (4.6)
Retired 213 (45.4) 182 (39.6)
Annual household income
(before tax), $
≤20 000 64 (13.6) 56 (12.2)
20 001-40 000 131 (27.9) 111 (24.1)
40 001-60 000 81 (17.3) 84 (18.3)
60 001-80 000 65 (13.9) 47 (10.2)
>80 001 105 (22.4) 127 (27.6)
Refused 23 (4.9) 35 (7.6)
Country of birth
Australia 363 (77.4) 360 (78.3)
Other 106 (22.6) 100 (21.7)
Has a physician ever deliberately
checked any part of your skin for
early signs of skin cancer?
Yes 379 (80.8) 380 (82.6)
No 90 (19.2) 80 (17.4)
In the past 12 mo has a physician
deliberately checked the skin on
your whole body?
Yes 182 (38.8) 180 (39.1)
No 287 (61.2) 280 (60.9)
Have you ever had a skin cancer,
mole, or other spot(s) removed
or treated?
Yes 333 (71.0) 327 (71.1)
No 136 (29.0) 133 (28.9)
a Data missing for 1 participant in the control group.
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Discussion
Althoughscreening formelanomabyCSE formenagedat least
50 yearsmaybe cost-effective,30 it is oftennot recommended
owing to the absence of evidence of amortality benefit in ran-
domized clinical trials. However, data are accumulating from
observational studies on the value of CSE for reducing mela-
noma thickness at diagnosis andmortality rates, highlighting
thebenefit formenagedat least 50years.16,31 This study found
that a video-based intervention designed to increase skin
awareness, SSE, and presentation to a physician with suspi-
cious skin lesions among men aged at least 50 years resulted
in a higher prevalence of self- and physician-reportedwhole-
bodyCSE than theprovisionofwrittenmaterials alone among
men who underwent any type of CSE. Among men who un-
derwent CSE, 34.1%had excision or biopsy of at least 1 lesion,
consistent with high levels of clinical suspicion for these le-
sions and highlighting the potential value of facilitating CSEs
in this group of older men in Australia.
Comparedwith thecontrol group,menreceiving thevideo
interventionweremore likely to self-reportundergoingwhole-
bodyCSE.Alsonotedby thephysicians, a larger proportionof
CSEs in interventionparticipants (74.5%)werewhole-bodyex-
aminations,whichwere recommended in the video interven-
tion tomake certain that lesionsondifficult-to-seebodyareas
were also assessed.6,32,33 Our analysis shows that men were
more likely to self-report CSEs if they had a regular physi-
cian, previous SSEs and/or CSEs, previous treatment of skin
lesionsormoles, or current concernabout a skin lesion, largely
similar to previous findings.34,35 The complementary nature
of SSE and CSE has been noted elsewhere in an investigation
of skin cancer early detection behavior among melanoma
survivors.36
A previous trial of a video-based intervention (theCheck-
It-Out trial),37,38 comparedSSEandCSEoutcomes among 1356
men andwomen (median age, 52 years). The intervention in-
cluded educational materials provided in paper-based and
video formats plus individual behavioral counseling (1 face-
to-face and 1 telephone session). Control participants re-
ceived the same attention but were counseled about healthy
diet. Participants randomized to the SSE group were signifi-
cantly more likely to undergo skin surgery during the first 6
months after the intervention (8%vs to 4% in the diet group).
The number of malignant lesions found was small compared
with our study (1 melanoma, 10 BCCs, and 3 SCCs), probably
because of the younger age group involved and the lower skin
cancer risk in the United States compared with Australia.8,38
Another trial that focusedon improving earlydetectionof
skin cancers inmen aged at least 50 years randomizedmen to
Table 2. Self-reported Outcomes of CSEsa
Outcome
Participants, No. (%)
P Valueb
Intervention
(n = 276)
Control
(n = 264)
Asked by physician to return for follow-up examination in the future 136 (49.3) 94 (35.6) .001
≥1 Lesion found during CSE 131 (47.5) 118 (44.7) .52
No. of lesions in participants with ≥1 lesion found, median (range) 2 (1-28) 2 (1-20) .85
≥1 Lesion treated during CSE 116 (42.0) 101 (38.3) .37
Course of treatment in participants with ≥1 lesion treated
Excision 59 (50.9) 43 (42.6) .22
Other treatment 57 (49.1) 58 (57.4)
Abbreviation: CSE, clinical skin
examination.
a Data represent number
(percentage) of participants unless
otherwise specified.
bP values determined with χ2 or
Wilcoxon rank sum tests.
Table 3. CSE Details Reported by Physicians
CSE Details
Control
(n = 107)
Intervention
(n = 104)
P
Valueb
Participants,
No. (%)a OR (95% CI)
Participants,
No. (%)a OR (95% CI)
Examination initiated by participant 59 (57.9) 1 [Reference] 66 (64.7) 1.34 (0.76-2.35) .31
Whole-body skin examination 62 (61.4) 1 [Reference] 76 (74.5) 1.84 (1.01-3.36) .046
Participants who received treatment,
monitoring, or referral because
of CSE
82 (76.6) 1 [Reference] 79 (76.0) 1.00 (0.53-1.90) .99
Participants whose lesions were
nonsurgically managed
54 (50.5) 1 [Reference] 50 (48.1) 0.91 (0.53-1.57) .73
Cryotherapy 47 (43.9) … 39 (37.5) …
Topical cream, monitoring, or
other nonsurgical treatment
7 (6.5) … 11 (10.6) …
Participants whose lesions were
surgically managed (excision
or biopsy)
29 (27.1) 1 [Reference] 43 (41.3) 1.90 (1.06-3.38) .03
Treated lesions, median (range), No.
Nonsurgical management 9 (1-30) … 3.5 (1-100) … …
Excision or biopsy 1 (1-5) … 1 (1-8) … …
Abbreviation: CSE, clinical skin
examination.
a Data represent number
(percentage) of participants unless
otherwise specified; denominators
vary slightly owing tomissing data.
bP values determined with univariate
logistic regression analysis.
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receive or not receive photographs of their skin to help detect
any changes in lesions.39 During the 2-year follow-up period,
34% underwent skin excision, similar to the 34.1% rate ob-
served inour study. Theproportions of cancers among the ex-
cised lesions (58% in the intervention and 42% in the control
group) were also similar to those observed in our study. Han-
rahan et al39 discussed whether this between-group differ-
ence in overall excised lesions may have reflected missed le-
sions in the absenceof photographs or treatment of lesions by
cryotherapy in thecontrol participants.However, inour study,
theproportions of participants treatedwith cryotherapywere
similar between the 2 groups.
Our findings indicate that in 76.3% of men with a CSE
reported by their physician, skin lesions were discovered
that required some form of management, of which 40.0%
and 60.0% were identified as skin cancers in the pathology
report in the control and intervention groups, respectively.
This may suggest that a targeted educational program such
as ours may lead to early detection of melanoma or other
skin cancers. Although the overall level of excisions may
seem high, we reported elsewhere that Australian general
practitioners are excellent at diagnosing skin cancer, need-
ing to excise a mean of just 2 skin lesions to find 1 skin
cancer.40 Furthermore, Fransen et al41(p566) reported that
“83% of NMSC [nonmelanoma skin cancer] treatments were
administered in people aged 55 years and over, and nearly
two-thirds of NMSC treatments were administered in per-
sons aged 65 years and over.”
Strengthsofourstudy include its focusonmenagedat least
50 years, a group at increased risk of dying of melanoma. Its
limitations include the fact that the men who agreed to par-
ticipate in the trial were already relatively skin aware at base-
line (39%self-reportedundergoingwhole-bodyCSEwithin the
12months before enrollment, with no difference between in-
terventionandcontrol groups).Our results could thereforeun-
derestimate the true effect of our interventionprogram, if less
health-aware men are assumed to be more likely to have un-
identifiedskincancers.A relatively lowproportionofmengave
consent for us to contact their physicians (321 of 540 [59.4%]),
mostly out of reluctance to creatework for their physician, al-
though the response rate fromphysicianswasgood (266of 321
[82.9%]). Thismeant thatCSEoutcomeswereavailable for 266
of 540 participants (49.3%) self-reporting a CSE. It is there-
fore likely that additional cancers were diagnosed but not re-
corded during the study. Men with fair phenotypes and pre-
vious skin excisions were more likely to consent to our
contacting their physician. Compared with men who con-
sented to physician follow-up,menwhodid not consent self-
reported fewer lesions being found during CSEs. If men who
did not give consent were at lower risk of skin cancer, our re-
sults may overestimate somewhat the number of skin can-
cers that could be diagnosed. As noted elsewhere,28 Skin
AwarenessStudyparticipantsmayhavebeenmorehealthcon-
scious than men from the general population, and 81.7% re-
ported at baseline having ever undergone any type of skin ex-
amination by a physician. Our results may therefore
overestimate what could be achieved in less health-
conscious men.
Conclusions
In summary, our trial showed that men aged at least 50 years
respondedfavorably tovideo-basededucation, increasing their
Table 4. Diagnoses ofMalignant Lesions Identified at CSE
Diagnosis
Lesions, No.
Control Group
(n = 107)
Intervention Group
(n = 104)
Melanoma 0 2
Squamous cell carcinoma 8 21
Basal cell carcinoma 10 28
All malignant lesions 18a 51a
Solar keratosis 2 15
Dysplastic nevus 1 2
Benign nevus 7 2
Other pigmented lesions 8 6
Other nonpigmented lesions 9 9
Total 45 85
Abbreviation: CSE, clinical skin examination.
a Of all lesions, 40.0%weremalignant in the control group and 60.0% in the
intervention group (P = .03; χ2 test).
Table 5. MultivariableModel Factors AssociatedWith Diagnosis
of Skin Cancer During the Triala
Factor
Odds Ratio
for Diagnosis
of Skin Cancer
(95% CI)
P
Value
Treatment arm
Intervention 1.45 (1.20-2.08)
.047
Control 1.00 [Reference]
Participant checked his own skin
within 6 mo before baseline
Yes 1.60 (1.04-2.48)
.03
No/unsure 1.00 [Reference]
Physician treatment of any particular spots
or skin lesions during the last skin check
Yes 1.78 (1.19-2.67)
.005
No 1.00 [Reference]
Deliberate checking by physician of any part
of participant's skin for early signs of skin cancer
within 12 mo before baseline
Yes 2.52 (1.21-5.23)
.01
No/don't know 1.00 [Reference]
Participant stays in the shade
Rarely/never 1.63 (1.10-2.43)
.02
Sometimes/usually/always 1.00 [Reference]
Participant’s skin response on exposure
to strong sun for 30 min
.04
Burn and not tan 0.89 (0.43-1.81) .74
Burn then tan 1.16 (0.65-2.06) .62
Tan slightly without burning 1.00 [Reference] …
Tan a lot without burning 3.24 (1.42-7.38) .005
a Of 929 participants, skin cancer was diagnosed in 40; some hadmore than
1 lesion. Diagnoses includedmalignant melanoma, squamous cell carcinoma,
and basal cell carcinoma.
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skin awareness and attendance at whole-body CSE during 7
monthsof follow-up.Amongmeninboth interventionandcon-
trol groups, many malignant lesions were diagnosed and
treated because of CSEs. We acknowledge that routine use of
CSE as a screening tool will place a burden on the health care
systemandcould lead to thedetectionof skin cancers that are
relatively indolent and may never cause death or significant
morbidity.22,25 However, with increasing evidence from ob-
servational studies supporting the effects of CSE in reducing
the incidence of thickmelanomas andmelanoma-associated
mortality rates16,31,42 and with evidence of potential reduc-
tions in the cost-benefit ratio,24 our results support imple-
menting behavioral interventions to encourage skin aware-
ness amongmen aged at least 50 years.
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NOTABLENOTES
The Forehead Scar as a Literary Device
Nicole Cresce, BS; Melissa A. Muszynski, MD; Scott A. Norton, MD, MPH
Dermatologists and patients often view scars as imperfections. In lit-
erature, however, scars can help define a nuanced character, often
revealing more than other aspects of a character’s appearance. Does
the scar connote bravery, some triumph in battle? Or, could it mean
something more sinister, a memento of treachery perhaps?
Forehead scars, in particular, are a frequently used literary device.
The earliest example of forehead scars may be the biblical tale of Cain
and Abel. God banished Cain for murdering his brother, Abel, but God
“setamarkuponCain, lest any findinghimshouldkill him.AndCainwent
out … and dwelt in the land of Nod, on the east of Eden” (Genesis 4:15,
King James Version). The Bible does not describe the mark, but some
Talmudic interpretations suggest it was a forehead scar shaped like sa-
cred Hebrew letters.
John Steinbeck’s novel, East of Eden, invokes Cain’s story, and fore-
head scars represent the struggle between good and evil. Thismodern
taleofCainandAbel involves2brothers, Charles andAdamTrask.When
Charles accidentally gashed his forehead, the resulting scar is allegori-
cal to the “mark upon Cain.” Another character, Adam’s wife, Cathy, is
anunremittingly evil, soulless creaturewhose “forehead [was] laidopen
totheskull”duringavengefulbeatingbyoneofhervictims; thescar sym-
bolizes her malevolence.1
Ahab, the monomaniacal whaling captain in Herman Melville’s
Moby-Dick, has a scar that “resembled that perpendicular seam some-
times made in the straight, lofty trunk of a great tree, when the upper
lightning tearingly darts down it… Whether that mark was born with
him, or whether it was the scar left by some desperate wound, no one
could certainly say.”2
J.K.Rowling3 introducedoneof themostmemorable foreheadscars
inmodern literature:HarryPotter’s lightningbolt.Diabolical LordVolde-
mort murdered Harry’s parents but “Instead of killing the small boy, …
Harry survivedwith nothing but a lightning-shaped cut on his forehead
andVoldemortwas reducedtosomethingbarelyalive.”3Despite thedark
origins ofHarry’s scar, hedoesnot view it as disfiguring, and, in fact, it is
the thing he likes most about his appearance.
Scars are powerful and timeless literary tools, and though the fre-
quent use of forehead scars to indicate intrinsic evil may work in lit-
erature, film, and comics, it does injustice to real people with real
scars.
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